Christopher Patusky, Director at UNITED THERAPEUTICS Corp (UTHR), sold 5,000 shares at $122.73 ($614K) on 2016-09-01, disclosed to the SEC on 2016-09-02.
Open-market sale of $614k UTHR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| UTHR | SELL | 2025-12-16 | $496K | — | Filing → |
| UTHR | SELL | 2025-03-20 | $3.0M | — | Filing → |
| UTHR | SELL | 2025-01-13 | $3.3M | — | Filing → |